Results 161 to 170 of about 37,814 (299)
Intravitreal ranibizumab for choroidal neovascularisation secondary to angioid streaks [PDF]
, 2009 Seungbum Kang, Young‐Jung Roh
openalex +1 more source
Current status of anti-vascular endothelial growth factor therapy in Europe [PDF]
, 2018 Vascular endothelial growth factor (VEGF) is an important modulator of angiogenesis, and has been implicated in the pathology of a number of conditions, including age-related macular degeneration (AMD), diabetic retinopathy, and cancer.
Wolf, Sebastian
core
Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration
, 2007 Peter K. Kaiser
openalex +2 more sources
Intravitreal ranibizumab for choroidal neovascularization secondary to acute multifocal posterior placoid pigment epitheliopathy [PDF]
, 2009 Nikolaos Mavrakanas +3 more
openalex +1 more source
Pharmacotherapy of Retinal Diseases with Ranibizumab [PDF]
, 2009 Daniel F. Kiernan +3 more
openalex +1 more source
Clinical Ophthalmology, 2013 Masahiro Miura,1,2 Takuya Iwasaki,1,2 Hiroshi Goto2 1Department of Ophthalmology, Tokyo Medical University, Ibaraki Medical Center, Ami, Ibaraki, Japan; 2Department of Ophthalmology, Tokyo Medical University, Nishi-Shinjuku, Tokyo, Japan Purpose: To ...
Miura M, Iwasaki T, Goto H
doaj
Effects of Intraocular Ranibizumab and Bevacizumab in Transgenic Mice Expressing Human Vascular Endothelial Growth Factor [PDF]
, 2009 Katsuaki Miki +5 more
openalex +1 more source
Clinical Ophthalmology, 2018 Ali Dirani, Irmela Mantel Department of Ophthalmology, University of Lausanne, Jules Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland Purpose: To investigate whether tolerance to the anti-VEGF drug, ranibizumab, develops after ...
Dirani A, Mantel I
doaj